Have you known that....
A facial filler complication can surface years , sometimes decades, after the original injection and still be mistaken for a tumor?
01
Common, But Not Risk-Free
Dermal fillers are the second most popular cosmetic medical treatment worldwide, and most injections are uneventful. But migration is a documented risk across filler types. One reported case showed hyaluronic acid migrating 16 years after injection, and the average delay before a biofilm-related complication appears is about 16 months, ranging from 3 months to 6 years.
02
Why These Cases Are So Easy to Miss
Delayed reactions can look like nodules, tumor-like masses, or chronic infection, sending patients through unnecessary biopsies or infectious workups before anyone identifies the filler as the cause. Meanwhile, results can differ by up to 40% between practitioners, and few offer imaging-guided monitoring. AI-assisted low-field MRI closes that gap by detecting filler and its migration more consistently than clinical exam alone, without the cost or wait time of a full diagnostic workflow.
03
Importance of Early Diagnosis and Advanced Tools
Left unaddressed, filler migration and biofilm reactions can progress into chronic inflammation, visible disfigurement, or infections that require surgery. Identifying the cause early. MyoMETRICS resolves most cases with a targeted, non-surgical treatment rather than an invasive one.
Save Fiancial Burden
A full diagnostic pathway for a facial filler concern runs roughly €1,000–€1,900 across the EU, US, and UAE
Track changes over time
A reliable way to monitor whether a filler is staying put, dissolving, or spreading, so clinics are diagnosing rather than guessing
Hide For Years
Migrated filler and biofilm reactions can surface months to years after the injection making them easy to miss and hard to trace
Do you know that....
DMD patients usually lose the ability to walk by age 12 and often die of respiratory failure or cardiac insufficiency around age 20
01
High Prevalence and Genetic Factors
Spinal Muscular Atrophy (SMA) is significantly more prevalent in the Gulf Cooperation Council (GCC) populations, with rates at least 50 times higher than in the US due to genetic factors like consanguinity. Duchenne Muscular Dystrophy (DMD), caused by a mutation on the X chromosome, primarily affects male children and leads to progressive muscle degeneration.
02
Challenges in Diagnosis and Progression
Traditional diagnostic methods for Duchenne Muscular Dystrophy (DMD) and Becker Muscular Dystrophy (BMD), such as muscle biopsies and high-field MRI scans, are limited by their financial burden, long time span, accuracy issues, and invasiveness. Low-field MRI combined with AI offers a more cost-efficient, faster, accurate, and non-invasive alternative, providing a comprehensive and reliable diagnosis while reducing patient discomfort and healthcare costs.
03
Importance of Early Diagnosis and Advanced Tools
The severe complications of DMD, including cardiac and respiratory issues, underscore the importance of early diagnosis and treatment to slow disease progression.
Therefore, there is a critical need for innovative, non-invasive diagnostic tools and comprehensive care plans to address these challenges. Our project aims to fill this gap by providing state-of-the-art diagnostic solutions and personalized care strategies.
Financial burden
The price of the MRI scans ranges from $110 to $2,000
in the United States and $110 to $1,100 in the UAE
Turnaround time
Muscle biopsies require several weeks for processing and analysis, while high-field MRI scans depend on the availability of specialized radiologists to interpret the results, leading to delays.
